
Join to view full profile
National Institutes Of Health10 Center Drive Msc 1876Bethesda, MD 20892
Phone+1 301-496-0491
Fax+1 301-496-0491
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Sneller, MD is an infectious disease specialist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1983 - 1986
Duke University HospitalResidency, Internal Medicine, 1980 - 1983
University of Kansas School of MedicineClass of 1979
Certifications & Licensure
MD State Medical License 1985 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsEarly Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption.Gesham Magombedze, Elena Vendrame, Devi SenGupta, Romas Geleziunas, Susan Little
The Journal of Infectious Diseases. 2025-02-20 - 4 citationsSustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir.M Ali Rai, Jana Blazkova, Lela Kardava, Jesse S Justement, Victoria Shi
Nature Medicine. 2025-02-01 - 2 citationsTiming of antiretroviral therapy initiation affects intact HIV reservoirs following analytical treatment interruption.Maegan R Manning, Jana Blazkova, Jesse S Justement, Victoria Shi, Brooke D Kennedy
The Journal of Clinical Investigation. 2024-10-15
Press Mentions
We Might Have Long Covid All WrongDecember 8th, 2022
Omicron Poses About Half the Risk of Long COVID as Delta, New Research FindsJune 17th, 2022
New Research Finds That Omicron Longs Nearly Half the Risk of COVID as DeltaJune 17th, 2022
Grant Support
- A Longitudinal Study of COVID-19 Sequelae and ImmunityNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESPresent









